NL1017205C2 - Medicinale en cosmetische toepassing van hop en co-enzym Q10. - Google Patents

Medicinale en cosmetische toepassing van hop en co-enzym Q10. Download PDF

Info

Publication number
NL1017205C2
NL1017205C2 NL1017205A NL1017205A NL1017205C2 NL 1017205 C2 NL1017205 C2 NL 1017205C2 NL 1017205 A NL1017205 A NL 1017205A NL 1017205 A NL1017205 A NL 1017205A NL 1017205 C2 NL1017205 C2 NL 1017205C2
Authority
NL
Netherlands
Prior art keywords
coenzyme
composition
hop
rye
buckwheat
Prior art date
Application number
NL1017205A
Other languages
English (en)
Dutch (nl)
Inventor
Adriaan Emanuel Hendricus Wiel
Marijke Christiaans
Original Assignee
Adriaan Emanuel Hendricus Wiel
Marijke Christiaans
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19772801&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NL1017205(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Adriaan Emanuel Hendricus Wiel, Marijke Christiaans filed Critical Adriaan Emanuel Hendricus Wiel
Priority to NL1017205A priority Critical patent/NL1017205C2/nl
Priority to PCT/NL2002/000054 priority patent/WO2002078727A1/en
Priority to DE60207988T priority patent/DE60207988D1/de
Priority to EP02710559A priority patent/EP1359928B1/de
Priority to PL36192902A priority patent/PL361929A1/xx
Priority to AT02710559T priority patent/ATE312618T1/de
Application granted granted Critical
Publication of NL1017205C2 publication Critical patent/NL1017205C2/nl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/348Cannabaceae
    • A61K36/3486Humulus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/70Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/899Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/35Ketones, e.g. benzophenone
    • A61K8/355Quinones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9794Liliopsida [monocotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
NL1017205A 2001-01-26 2001-01-26 Medicinale en cosmetische toepassing van hop en co-enzym Q10. NL1017205C2 (nl)

Priority Applications (6)

Application Number Priority Date Filing Date Title
NL1017205A NL1017205C2 (nl) 2001-01-26 2001-01-26 Medicinale en cosmetische toepassing van hop en co-enzym Q10.
PCT/NL2002/000054 WO2002078727A1 (en) 2001-01-26 2002-01-24 Medicinal and cosmetic use of hop and co-enzyme q10
DE60207988T DE60207988D1 (de) 2001-01-26 2002-01-24 Medizinische und kosmetische verwendung von hopfen und coenzym q10
EP02710559A EP1359928B1 (de) 2001-01-26 2002-01-24 Medizinische und kosmetische verwendung von hopfen und coenzym q10
PL36192902A PL361929A1 (pl) 2001-01-26 2002-01-24 Medyczne i kosmetyczne zastosowanie chmielu i ko-enzymu Q 10
AT02710559T ATE312618T1 (de) 2001-01-26 2002-01-24 Medizinische und kosmetische verwendung von hopfen und coenzym q10

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1017205 2001-01-26
NL1017205A NL1017205C2 (nl) 2001-01-26 2001-01-26 Medicinale en cosmetische toepassing van hop en co-enzym Q10.

Publications (1)

Publication Number Publication Date
NL1017205C2 true NL1017205C2 (nl) 2002-07-29

Family

ID=19772801

Family Applications (1)

Application Number Title Priority Date Filing Date
NL1017205A NL1017205C2 (nl) 2001-01-26 2001-01-26 Medicinale en cosmetische toepassing van hop en co-enzym Q10.

Country Status (6)

Country Link
EP (1) EP1359928B1 (de)
AT (1) ATE312618T1 (de)
DE (1) DE60207988D1 (de)
NL (1) NL1017205C2 (de)
PL (1) PL361929A1 (de)
WO (1) WO2002078727A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101395370B1 (ko) * 2004-01-22 2014-05-14 유니버시티 오브 마이애미 국소용 코-엔자임 큐10 제형 및 그의 사용 방법
WO2006017494A2 (en) * 2004-08-02 2006-02-16 Elizabeth Mazzio Inhibition of anaerobic glucose metabolism
WO2007013556A1 (ja) * 2005-07-28 2007-02-01 Kaneka Corporation 癌予防用組成物
MX337408B (es) 2007-03-22 2016-03-03 Berg Llc Formulaciones topicas que tienen biodisponibilidad aumentada.
MX2010011032A (es) 2008-04-11 2011-03-01 Cytotech Labs Llc Star Metodos y uso de induccion de apoptosis en celulas cancerigenas.
CN102481271A (zh) 2009-05-11 2012-05-30 博格生物系统有限责任公司 利用表观代谢转变剂、多维细胞内分子或环境影响剂治疗代谢障碍的方法
SG10202010355PA (en) 2010-03-12 2020-11-27 Berg Llc Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof
CA2832324C (en) 2011-04-04 2022-03-15 Berg Llc Methods of treating central nervous system tumors
EP2720680B1 (de) 2011-06-17 2020-02-12 Berg LLC Inhalbierbare pharmazeutische zusammensetzungen
NZ713868A (en) 2013-04-08 2021-12-24 Berg Llc Treatment of cancer using coenzyme q10 combination therapies
KR102370843B1 (ko) 2013-09-04 2022-03-04 버그 엘엘씨 코엔자임 q10의 연속주입에 의한 암치료 방법
CN104623453A (zh) * 2015-01-20 2015-05-20 刘保和 治疗妇女乳痰的药物制剂及制备
WO2017087576A1 (en) 2015-11-16 2017-05-26 Berg Llc Methods of treatment of temozolomide-resistant glioma using coenzyme q10

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52145509A (en) * 1976-05-27 1977-12-03 Tokutarou Matsui Antitumor agent
CN1031021A (zh) * 1987-07-24 1989-02-15 天津市化妆品科学技术研究所 女性乳房健美化妆品

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52145509A (en) * 1976-05-27 1977-12-03 Tokutarou Matsui Antitumor agent
CN1031021A (zh) * 1987-07-24 1989-02-15 天津市化妆品科学技术研究所 女性乳房健美化妆品

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CLINICAL BIOCHEMISTRY, vol. 33, no. 4, June 2000 (2000-06-01), pages 279 - 284, ISSN: 0009-9120 *
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; June 2000 (2000-06-01), PORTAKAL OYTUN ET AL: "Coenzyme Q10 concentrations and antioxidant status in tissues of breast cancer patients.", XP002180330, Database accession no. PREV200000488189 *
DATABASE WPI Section Ch Week 197803, Derwent World Patents Index; Class B04, AN 1978-05666A, XP002180331 *
DATABASE WPI Section Ch Week 199006, Derwent World Patents Index; Class B05, AN 1990-037332, XP002180332 *
LOCKWOOD K ET AL: "Apparent partial remission of breast cancer in 'high risk' patients supplemented with nutritional antioxidants, essential fatty acids and coenzyme Q10", MOLECULAR ASPECTS OF MEDICINE, PERGAMON PRESS, OXFORD, GB, vol. 15, no. SUPPL, 1994, pages S231 - S240, XP002108766, ISSN: 0098-2997 *

Also Published As

Publication number Publication date
WO2002078727A1 (en) 2002-10-10
PL361929A1 (pl) 2004-10-18
EP1359928B1 (de) 2005-12-14
ATE312618T1 (de) 2005-12-15
DE60207988D1 (de) 2006-01-19
EP1359928A1 (de) 2003-11-12

Similar Documents

Publication Publication Date Title
Man et al. Iron supplementation and iron-fortified foods: a review
NL1017205C2 (nl) Medicinale en cosmetische toepassing van hop en co-enzym Q10.
JP5509503B2 (ja) ビタミンdと25−ヒドロキシビタミンd3の組み合わせ
KR101561717B1 (ko) 인간의 근육 생리에 영향을 미치는 25-하이드록시-비타민 d3의 용도
JP2011512343A (ja) 骨塩密度を改善し、骨粗鬆症を治療するための25−ヒドロキシ−ビタミンd3とビタミンd3の併用
TW201347681A (zh) 含有咪唑胜肽與槲黃素配糖體之組成物
JP2016506381A (ja) シクロデキストリンを含むカテキン生体利用率増進剤
CN103404594A (zh) 一种具有促进排铅作用的功能性乳品及其制备方法
US8105637B2 (en) Composition comprising nanoparticle Ginkgo biloba extract with the effect of brain function activation
Hecht et al. Dose–response study of myo-inositol as an inhibitor of lung tumorigenesis induced in A/J mice by benzo [a] pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone
JP3001880B1 (ja) 麦若葉末を含有する食品
EP3225245A1 (de) Vicia faba extrakt und seine verwendung zur behandlung und/oder vorbeugung neurodegenerativer erkrankungen
NL1014751C2 (nl) Middel ter bevordering van borstgroei.
JPH1156299A (ja) ビタミン群含有加工食品
US20030044475A1 (en) Cosmetic use of hop and ornithine
NL1018637C2 (nl) Cosmetische toepassing van hop en choline en/of cystine.
JP2010090097A (ja) 抗骨粗鬆症組成物
BE1016971A6 (nl) Cosmetische toepassing van hop en rode klaver.
NL1011529C2 (nl) Middel ter onderdrukking en preventie van de kwaadaardige groei van kankercellen.
AU2001242882A1 (en) Cosmetic use of hop and ornithine
WO2015190682A1 (ko) 쿠마린산을 유효성분으로 포함하는 성장 촉진용 조성물
US10799452B2 (en) Sublingual therapeutic solutions and methods
EP3441062B1 (de) Meerwasser und salzpulverausgleichsformulierungen und pharmazeutische und nahrungszusammensetzungen
CN107006864A (zh) 多肽白藜芦醇制剂及其制备方法和应用以及包含其的保健品或药物组合物
JP2021052802A (ja) フェルラ酸含有飲料

Legal Events

Date Code Title Description
PD2B A search report has been drawn up
SD Assignments of patents

Owner name: B.A.S.A. SARL

VD1 Lapsed due to non-payment of the annual fee

Effective date: 20060801